Tappet

← Back to Tappet
Philadelphia feed of tappet.org
Health Care · Nov 19, 2026

The Desmoid Tumor Research Foundation Inc - Immunome Announces EMA Validation of Marketing Authorization Application for Varegac

Read Immunome’s Press Release BOTHELL, Wash. – Immunome, Inc. (Nasdaq: IMNM), a clinical-stage targeted oncology company committed to developing first-in-class and best-in-class targeted cancer therapies, today announced that the European […] The post Immunome Announces EMA Validation of Marketing Authorization Application for Varegacestat for the Treatment of Adults with Desmoid Tumors appeared first on The Desmoid Tumor Research Foundation .

https://dtrf.org/about-dtrf/news-updates/immunome-announces-ema-validation-of-marketing-authorization-application-for-varegacestat-for-the-treatment-of-adults-with-desmoid-tumors/

Join the conversation on Tappet